Results 281 to 290 of about 95,044 (332)

Circulating MicroRNAs in Idiopathic Pulmonary Fibrosis: A Narrative Review. [PDF]

Curr Issues Mol Biol
Colin Waldo MD, Quintero-Millán X, Negrete-García MC, Ruiz V, Sommer B, Romero-Rodríguez DP, Montes-Martínez E.   +6 more
europepmc   +1 more source

Quantifying Spatial Distribution of Ventilation Defects in Multiple Pulmonary Diseases With Hyperpolarized 129Xenon MRI

Journal of Magnetic Resonance Imaging, Volume 61, Issue 4, Page 1860-1873, April 2025.
Background Hyperpolarized 129Xe MRI assesses lung ventilation, often using the ventilation defect percentage (VDP). Unlike VDP, defect distribution index (DDI) quantifies spatial clustering of defects. Purpose To quantify spatial distribution of 129Xe ventilation defects using DDI across pulmonary diseases. Study Type Retrospective.
Abdullah S. Bdaiwi, Matthew M. Willmering, Jason C. Woods, Laura L. Walkup, Zackary I. Cleveland   +4 more
wiley   +1 more source

<i>MUC5B</i> Polymorphism in Patients with Idiopathic Pulmonary Fibrosis-Does It Really Matter? [PDF]

Int J Mol Sci
Lewandowska KB, Lechowicz U, Roży A, Falis M, Błasińska K, Jakubowska L, Franczuk M, Żołnowska B, Gryczka-Wróbel J, Radwan-Rohrenschef P, Lewandowska A, Witczak-Jankowska O, Sobiecka M, Szturmowicz M, Tomkowski WZ.   +14 more
europepmc   +1 more source

Immunological Features and Potential Biomarkers of Systemic Sclerosis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis. [PDF]

Clin Respir J
Shao S, Cao S, Chen Y, Zhang Z, Zhaohui T.   +4 more
europepmc   +1 more source

Genetic variation reveals the therapeutic potential of BRSK2 in idiopathic pulmonary fibrosis. [PDF]

BMC Med
Chen Z, Tang M, Wang N, Liu J, Tan X, Ma H, Luo J, Xie K.   +7 more
europepmc   +1 more source

Impact of catheter ablation for ventricular tachycardia on left ventricular ejection fraction in patients with structural heart disease

Journal of Arrhythmia, Volume 41, Issue 2, April 2025.
This study investigates the left ventricular ejection fraction (LVEF) before and after catheter ablation for ventricular tachycardia in patients with structural heart disease. Patients with severely impaired pre‐ablation LVEF demonstrated mild restoration in LVEF following ablation.
Ashish Sood, Samual Turnbull, Kasun De Silva, Ashwin Bhaskaran, Richard G. Bennett, Timothy G. Campbell, Liza Thomas, Saurabh Kumar   +7 more
wiley   +1 more source

STAT3 Signaling Pathway in Health and Disease

MedComm, Volume 6, Issue 4, April 2025.
An image depicting the role of STAT3 in various human diseases ABSTRACT Signal transducer and activator of transcription 3 (STAT3) is a critical transcription factor involved in multiple physiological and pathological processes. While STAT3 plays an essential role in homeostasis, its persistent activation has been implicated in the pathogenesis of ...
Md Abdus Samad, Iftikhar Ahmad, Aakifah Hasan, Mohammad Hassan Alhashmi, Arusha Ayub, Fahad A. Al‐Abbasi, Ajoy Kumer, Shams Tabrez   +7 more
wiley   +1 more source

Proteomic Approach to Study the Effect of Pneumocystis jirovecii Colonization in Idiopathic Pulmonary Fibrosis. [PDF]

J Fungi (Basel)
Carmona-Pírez J, Salsoso R, Charpentier E, Olmedo C, Medrano FJ, Román L, de la Horra C, de Armas Y, Calderón EJ, Friaza V.   +9 more
europepmc   +1 more source

Proteoglycans and Hyaluronan in Normal and Aberrant Lung Development

Proteoglycan Research, Volume 3, Issue 2, April 2025.
ABSTRACT Lung development is a tightly regulated process that progresses through five distinct stages: embryonic, pseudoglandular, canalicular, saccular, and alveolar. Each stage is characterized by coordinated cellular interactions and structural changes driven by signals from epithelial, endothelial, and mesenchymal cells.
Andrea Reszegi, Gabor Petovari, Nikitha Damisetty, Stavros Garantziotis, Rashmin C. Savani   +4 more
wiley   +1 more source

Pediatric Pulmonology 2024 Year in Review: Rare and Diffuse Lung Disease

Pediatric Pulmonology, Volume 60, Issue 4, April 2025.
ABSTRACT The field of pediatric rare and diffuse lung diseases continues to advance, with ongoing research deepening our understanding of the diagnosis and treatment of conditions such as children's interstitial and diffuse lung disease (chILD), non‐cystic fibrosis (CF) bronchiectasis, and pulmonary complications of childhood cancer.
Pi Chun Cheng, Deborah R. Liptzin, Katiana Garagozlo, Andrew T. Barber   +3 more
wiley   +1 more source